Cochran Christopher P. — SEC Form 4 filings

SEC reporting owner CIK 1951916. 3 Form 4 filings on record with FilingPulse; latest filed 2026-02-13.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-01-09 to 2026-02-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Coeptis Therapeutics Holdings, Inc. (COEP)Director31 leg · 7,000 sh · $5,3903

Form 4 filings — Cochran Christopher P.

FiledFormIssuerReported transactionsSource
2026-02-134Coeptis Therapeutics Holdings, Inc. (COEP)Option exercise (M): 5,700 @ $10.56 · Grant/award (A): 3,250 @ $0EDGAR
2025-03-064Coeptis Therapeutics Holdings, Inc. (COEP)Grant/award (A): 5,700 (derivative)EDGAR
2024-01-094Coeptis Therapeutics Holdings, Inc. (COEP)Purchase (P): 7,000 @ $0.77EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1951916 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →